-
Fast paced trial chasing down COVID-19 symtoms
pharmatimes
January 27, 2022
Ground-breaking trial run by Oxford University has recruited 5000 people and will focus on severe COVID-19 symptoms.
-
Oxford University and Oracle Partner to Speed Identification of COVID-19 Variants
americanpharmaceuticalreview
May 18, 2021
The emergence of more infectious variants of the COVID-19 virus is threatening to slow the global recovery and potentially thwart current vaccine immunity.
-
Prenetics Signs Multi-million Dollar Collaboration with Oxford University for Advanced Molecular Diagnostics
prnasia
April 20, 2021
Prenetics Limited, a global leader in diagnostics and genetic testing, Oxford University and Oxford Suzhou Centre for Advanced Research (OSCAR) have signed multi-million dollar collaboration agreements to further develop the award-winning OxLAMP™ ...
-
Common asthma drug speeds up Covid-19 recovery at home, study finds
pharmaceutical-technology
April 14, 2021
Oxford University researchers have found that a cheap asthma drug can help speed up recovery for people at home with Covid-19.
-
Biotech start-up Vaccitech files for US IPO
expresspharma
April 12, 2021
Vaccitech owns the technology behind the COVID-19 vaccine developed by Oxford University and AstraZeneca.
-
EMA review concludes AstraZeneca Covid-19 vaccine is “safe and effective”
pharmaceutical-technology
March 19, 2021
The European Medicines Agency (EMA) has concluded that the AstraZeneca/Oxford University Covid-19 vaccine is “safe and effective” after an investigation into a potential link between the vaccine and blood clots in a small number of patients.
-
Oxford University to develop Alzheimer’s disease treatments with Exscientia
pharmatimes
February 22, 2021
The Alzheimer’s Research UK Oxford Drug Discovery Institute (ARUK-ODDI) has announced a partnership with AI drug discovery company Exscientia on the development of therapies for Alzheimer’s disease.
-
Serbia gets shipment of AstraZeneca COVID-19 vaccine made in India
expresspharma
February 22, 2021
A shipment of 150,000 COVID-19 vaccines developed by AstraZeneca and Oxford University arrived at Belgrade airport on Sunday, making Serbia the first country in the Western Balkan region to receive supplies of the shot.
-
Oxford University launches Covid-19 vaccine study in children
pharmaceutical-technology
February 18, 2021
The University of Oxford has launched the first study of ChAdOx1 nCoV-19 Covid-19 vaccine in children and young adults.
-
INEOS, Oxford University to set up institute for antimicrobial research
expresspharma
January 20, 2021
INEOS donates £100 million to Oxford Univerity to set up the new institute to fight antimicrobial resistance.